Found: 26
Select item for more details and to access through your institution.
Role of chemotherapy in the treatment of metastatic castration-resistant prostate cancer patients who have progressed after abiraterone acetate.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 439, doi. 10.1007/s00280-015-2803-y
- By:
- Publication type:
- Article
Reproductive hormone levels and differential mitochondria-related oxidative gene expression as potential mechanisms for gender differences in cardiosensitivity to Doxorubicin in tumor-bearing spontaneously hypertensive rats.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 447, doi. 10.1007/s00280-015-2786-8
- By:
- Publication type:
- Article
AT-101 inhibits hedgehog pathway activity and cancer growth.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 461, doi. 10.1007/s00280-015-2812-x
- By:
- Publication type:
- Article
NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K-AKT cascade.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 471, doi. 10.1007/s00280-015-2794-8
- By:
- Publication type:
- Article
NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K-AKT cascade.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 481, doi. 10.1007/s00280-015-2814-8
- By:
- Publication type:
- Article
Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 489, doi. 10.1007/s00280-015-2788-6
- By:
- Publication type:
- Article
Safety of topotecan monotherapy for relapsed small cell lung cancer patients with pre-existing interstitial lung disease.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 499, doi. 10.1007/s00280-015-2816-6
- By:
- Publication type:
- Article
Integrated nonclinical and clinical risk assessment of the investigational proteasome inhibitor ixazomib on the QTc interval in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 507, doi. 10.1007/s00280-015-2815-7
- By:
- Publication type:
- Article
A phase II study of icotinib and whole-brain radiotherapy in Chinese patients with brain metastases from non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 517, doi. 10.1007/s00280-015-2760-5
- By:
- Publication type:
- Article
In vivo pharmacokinetic and tissue distribution investigation of sustained-release cisplatin implants in the normal esophageal submucosa of 12 beagle dogs.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 525, doi. 10.1007/s00280-015-2823-7
- By:
- Publication type:
- Article
Characterization of the metabolism of benzaldehyde dimethane sulfonate (NSC 281612, DMS612).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 537, doi. 10.1007/s00280-015-2828-2
- By:
- Publication type:
- Article
A phase II study of S-1, oxaliplatin, oral leucovorin, and bevacizumab combination therapy (SOLA) in patients with unresectable metastatic colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 547, doi. 10.1007/s00280-015-2825-5
- By:
- Publication type:
- Article
Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 555, doi. 10.1007/s00280-015-2821-9
- By:
- Publication type:
- Article
Modeling and simulations relating overall survival to tumor growth inhibition in renal cell carcinoma patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 567, doi. 10.1007/s00280-015-2820-x
- By:
- Publication type:
- Article
Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 575, doi. 10.1007/s00280-015-2749-0
- By:
- Publication type:
- Article
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 587, doi. 10.1007/s00280-015-2830-8
- By:
- Publication type:
- Article
A phase 1 study of intermittently administered pazopanib in combination with continuous daily dosing of lapatinib in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 597, doi. 10.1007/s00280-015-2824-6
- By:
- Publication type:
- Article
S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 605, doi. 10.1007/s00280-015-2834-4
- By:
- Publication type:
- Article
A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 615, doi. 10.1007/s00280-015-2835-3
- By:
- Publication type:
- Article
Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 621, doi. 10.1007/s00280-015-2831-7
- By:
- Publication type:
- Article
A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 631, doi. 10.1007/s00280-015-2832-6
- By:
- Publication type:
- Article
Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 641, doi. 10.1007/s00280-015-2822-8
- By:
- Publication type:
- Article
Cisplatin-based chronotherapy for advanced non-small cell lung cancer patients: a randomized controlled study and its pharmacokinetics analysis.
- Published in:
- 2015
- By:
- Publication type:
- Report
RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 657, doi. 10.1007/s00280-015-2802-z
- By:
- Publication type:
- Article
RETRACTED ARTICLE: ABCB1 (1199G>A) polymorphism regulates the efficacy of docetaxel and imatinib mesylate in HEK293 recombinant cell lines.
- Published in:
- 2015
- By:
- Publication type:
- corrected article